GL1X · GenesisL1 explorer

MolNFT v1 · #28357 · protein

Structure of trihydroxynaphthalene reductase in complex with NADPH and an active site inhibitor

1YBV: “Structure of trihydroxynaphthalene reductase in complex with NADPH and an active site inhibitor”. X-ray diffraction, 2 ligands (NDP, BEA), 5 pockets (best druggability 0.78). MolNFT v1 #28357 on GenesisL1: 3D structure, binding…

PDB
1YBV
Type
protein
Length
540 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Trihydroxynaphthalene reductase
EC
1.3.1.50
UniProt
Q12634
Ligands
NDP, BEA
Pockets
5 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 50% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BTrihydroxynaphthalene reductase (EC 1.3.1.50)protein27050% helix, 15% strandQ12634

Ligands and binding sites

  • NDP · Nadph dihydro-nicotinamide-adenine-dinucleotide phosphate · ligand · 2 copies · chains A, B
  • BEA · 5-methyl-1,2,4-triazolo[3,4-b]benzothiazole · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13850.780.8743NDP, BEA
23990.770.8643NDP, BEA
34480.620.7646empty
4850.380.7715empty
5710.370.7814empty

Interfaces

1 interface between chains.

  • A–B · 2062 Ų buried · 29 hydrogen bonds · protein-protein

Compared structures

  • 1YBV · Structure of trihydroxynaphthalene reductase in complex with NADPH and an active site… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q12634 · AlphaFold monomer V2.0 prediction for tetrahydroxynaphthalene reductase (Q12634) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.